Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma
Clinical trial NCT00939484 · COMPLETED
Trial details
- NCT number
- NCT00939484
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2013-05-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.